ICH Q11 Q&A - A Supporting Document for the Selection and Justification of Starting Materials

  Рет қаралды 3,618

U.S. Food and Drug Administration

U.S. Food and Drug Administration

Күн бұрын

Пікірлер
Drug Substance Facilities - Hidden and Critical Intermediate
24:59
U.S. Food and Drug Administration
Рет қаралды 2,5 М.
Safety Reporting Requirements and Safety Assessment for IND and BA/BE Studies
35:38
U.S. Food and Drug Administration
Рет қаралды 9 М.
UFC 308 : Уиттакер VS Чимаев
01:54
Setanta Sports UFC
Рет қаралды 849 М.
啊?就这么水灵灵的穿上了?
00:18
一航1
Рет қаралды 103 МЛН
Random Emoji Beatbox Challenge #beatbox #tiktok
00:47
BeatboxJCOP
Рет қаралды 22 МЛН
НИКИТА ПОДСТАВИЛ ДЖОНИ 😡
01:00
HOOOTDOGS
Рет қаралды 3,1 МЛН
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018
44:31
Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018
33:18
ICH Q12 Guidance and Emerging Technology Program (11of16) Generic Drugs Forum 2020
55:12
U.S. Food and Drug Administration
Рет қаралды 3,6 М.
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 1
1:31:22
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 1
1:33:53
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 2 - Part 3
1:52:53
ICH M12 Drug-Drug Interaction Studies Final Guidance
1:54:10
U.S. Food and Drug Administration
Рет қаралды 611
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 4
1:01:38
Advancing Generic Drug Development: Translating Science to Approval 2024 - Day 1 - Part 2
1:12:08
Global IDMP Implementation - Getting Closer to the Goal
1:25:26
U.S. Food and Drug Administration
Рет қаралды 390
UFC 308 : Уиттакер VS Чимаев
01:54
Setanta Sports UFC
Рет қаралды 849 М.